10-Q Filing

LifeMD, Inc. CIK: 948320 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-011996`
Period End Date	20170930
Filing Date	20171114
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	immd-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 72 Cash Flow Statement 79 Stockholders Equity 25

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Treasury stock, common shares	`TreasuryStockCommonShares`	515,200.00	shares	Point-in-time
Treasury stock, common shares	`TreasuryStockCommonShares`	325,000.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$562.76K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.57M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$276.99K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	217,391.00	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$444.74K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.26M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.74M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.25M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.25K	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Product deposit	`DepositAssets`	-	USD	Point-in-time
Product deposit	`DepositAssets`	$119.90K	USD	Point-in-time
Inventory, net	`InventoryNet`	$160.27K	USD	Point-in-time
Inventory, net	`InventoryNet`	$377.80K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$789.82K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.34M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$699.65K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$752.93K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$192.25K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	$100.00K	USD	Point-in-time
Notes payable, net of discount in 2016	`NotesPayableCurrent`	$77.33K	USD	Point-in-time
Notes payable, net of discount in 2016	`NotesPayableCurrent`	$106.36K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.15M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$776.98K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,257,342 and 35,570,157 shares issued, 43,742,142 and 35,245,157 outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$355.70K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,257,342 and 35,570,157 shares issued, 43,742,142 and 35,245,157 outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$442.57K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.07M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-10.68M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-9.69M	USD	Point-in-time
Equity	`Equity`	$981.30K	USD	Point-in-time
Equity	`Equity`	$-268.12K	USD	Point-in-time
Treasury stock, 515,200 and 325,000 shares, at cost	`TreasuryStockValue`	$87.05K	USD	Point-in-time
Treasury stock, 515,200 and 325,000 shares, at cost	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-355.17K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$817.60K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-6.55K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-257.13K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$560.47K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$789.82K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.34M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`Revenues`	$2.05M	USD	1 Quarter
Net Sales	`Revenues`	$1.38M	USD	1 Quarter
Net Sales	`Revenues`	$3.58M	USD	3 Qtrs
Net Sales	`Revenues`	$4.25M	USD	3 Qtrs
Cost of Sales	`CostOfRevenue`	$1.27M	USD	3 Qtrs
Cost of Sales	`CostOfRevenue`	$1.07M	USD	3 Qtrs
Cost of Sales	`CostOfRevenue`	$388.20K	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$535.57K	USD	1 Quarter
Gross Profit	`GrossProfit`	$1.52M	USD	1 Quarter
Gross Profit	`GrossProfit`	$2.52M	USD	3 Qtrs
Gross Profit	`GrossProfit`	$996.23K	USD	1 Quarter
Gross Profit	`GrossProfit`	$2.98M	USD	3 Qtrs
Compensation and related expenses	`LaborAndRelatedExpense`	$361.83K	USD	1 Quarter
Compensation and related expenses	`LaborAndRelatedExpense`	$1.08M	USD	3 Qtrs
Compensation and related expenses	`LaborAndRelatedExpense`	$529.36K	USD	1 Quarter
Compensation and related expenses	`LaborAndRelatedExpense`	$1.13M	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$321.55K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$99.96K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$82.61K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$277.28K	USD	3 Qtrs
Marketing expenses	`MarketingExpense`	$1.71M	USD	3 Qtrs
Marketing expenses	`MarketingExpense`	$882.85K	USD	1 Quarter
Marketing expenses	`MarketingExpense`	$554.54K	USD	1 Quarter
Marketing expenses	`MarketingExpense`	$1.18M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$204.96K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$382.86K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$753.40K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$277.56K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.20M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.39M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.45M	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-273.57K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-207.70K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-874.03K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-466.43K	USD	3 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	3 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$377.21K	USD	1 Quarter
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$-496.62K	USD	3 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	$650.72K	USD	3 Qtrs
Interest (expense)	`InterestExpense`	$9.99K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$15.80K	USD	3 Qtrs
Interest (expense)	`InterestExpense`	$1.11K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-651.89K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-1.03M	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.44K	USD	3 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-41.75K	USD	3 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.96K	USD	1 Quarter
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.17K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-226.65K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-986.38K	USD	3 Qtrs
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-679.06K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-488.68K	USD	3 Qtrs
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	31.92M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	34.43M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.16M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	40.89M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.16M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.89M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.43M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.92M	shares	3 Qtrs

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-226.65K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-986.38K	USD	3 Qtrs
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-679.06K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-488.68K	USD	3 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.44K	USD	3 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-41.75K	USD	3 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.96K	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.17K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-651.89K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-1.03M	USD	3 Qtrs
Net (Loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	3 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	$-496.62K	USD	3 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-43.56K	USD	3 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-49.12K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$25.04K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$81.56K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$5.99K	USD	3 Qtrs
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	$-634.33K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$493.22K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	-	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$79.69K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$162.74K	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	-	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	$20.59K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$498.93K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-216.87K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$276.93K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-2.25K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Product deposit	`IncreaseDecreaseInDeposits`	-	USD	3 Qtrs
Product deposit	`IncreaseDecreaseInDeposits`	$-119.90K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$69.48K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$217.53K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$240.71K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-1.07K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-315.69K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-111.70K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$63.38K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$161.35K	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$150.00K	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$386.38K	USD	3 Qtrs
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	$100.00K	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$250.46K	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$673.25K	USD	3 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$46.00K	USD	3 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-76.65K	USD	3 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-4.72K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$352.63K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$695.89K	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$240.94K	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$380.20K	USD	3 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$562.76K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$562.76K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$4.72K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	$8.56K	USD	3 Qtrs
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	$242.19K	USD	3 Qtrs
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	-	USD	3 Qtrs
Issuance of common stock for conversion of debt	`IssuanceOfCommonStockForConversionOfDebt`	-	USD	3 Qtrs
Issuance of common stock for conversion of debt	`IssuanceOfCommonStockForConversionOfDebt`	-	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationDebtOffering`	-	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationDebtOffering`	$41.88K	USD	3 Qtrs
Issuance of common stock for services	`IssuanceOfCommonStockForServices`	-	USD	3 Qtrs
Issuance of common stock for services	`IssuanceOfCommonStockForServices`	$581.09K	USD	3 Qtrs
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	$272.20K	USD	3 Qtrs
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	-	USD	3 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	-	USD	3 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	$255.14K	USD	3 Qtrs

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$560.47K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$230.00K	USD	3 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$84.17K	USD	1 Quarter
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$498.93K	USD	3 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$673.25K	USD	3 Qtrs
Conversion of non-controlling interest equity for shares and warrants	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	3 Qtrs
Conversion of note payable	`StockIssuedDuringPeriodValueOther`	$189.98K	USD	3 Qtrs
Loss on settlement of notes and other payables	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$634.33K	USD	3 Qtrs
Conversion of accrued expenses	`StockIssuedDuringPeriodValueConversionOfAccruedExpenses`	$52.21K	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$58.75K	USD	Point-in-time
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$56.52K	USD	3 Qtrs
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	62,500.00	shares	3 Qtrs
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	250,000.00	shares	Point-in-time
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$76.65K	USD	3 Qtrs
Issuance of stock options for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$113.52K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest, net of distributions	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$63.38K	USD	3 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReclassificationOfOptionsWarrantsAndOtherContractsFromEquityToDerivativeLiabilities`	$-255.14K	USD	3 Qtrs
Net (loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-651.89K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-1.03M	USD	3 Qtrs
Net (loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$560.47K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.